Target Name: MIR3939
NCBI ID: G100500857
Other Name(s): hsa-miR-3939 | hsa-mir-3939 | mir-3939 | microRNA 3939 | MicroRNA 3939

MIR3939: A Drug Target / Disease Biomarker

MIR3939, a drug target (or biomarker) for cancer, has been identified and characterized. MIR3939 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in various cell types and has been associated with various diseases, including cancer.

The discovery and characterization of MIR3939 as a potential drug target or biomarker has important implications for the development of new cancer therapies. MIR3939 has been shown to be involved in the regulation of cell proliferation, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). These processes are closely associated with cancer development and progression.

In cancer, MIR3939 is often overexpressed, which leads to its accumulation in the cells and the formation of new cancer cells. Overexpression of MIR3939 has been shown to promote the growth and survival of various cancer cell types, including breast, ovarian, and colorectal cancer.

The potential drug target status of MIR3939 is further supported by its expression in various cancer tissues and its effects on cancer cell lines. For example, studies have shown that MIR3939 can be downregulated in cancer cells, leading to the inhibition of cell proliferation and the suppression of cancer cell survival.

In addition to its potential as a drug target, MIR3939 also has the potential as a biomarker for cancer diagnosis and treatment. Its overexpression is often associated with cancer, making it a promising biomarker for cancer detection and monitoring. For example, studies have shown that MIR3939 can be used as a diagnostic marker for breast cancer, with higher expression levels of MIR3939 being associated with a more aggressive cancer.

In conclusion, the characterization of MIR3939 as a potential drug target and biomarker for cancer has important implications for the development of new cancer therapies. Further research is needed to fully understand the role of MIR3939 in cancer biology and to develop effective strategies for its targeting. However, the identification and characterization of MIR3939 as a potential drug target and biomarker for cancer is a promising step in this direction.

Protein Name: MicroRNA 3939

More Common Targets

MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320